 New concepts treatment stage adenocarcinoma prostate Stage disease cent patients prostate cancer marked heterogeneity cancers stage disease-free survival rates cent prostate cancer confines gland metastasis occurs widespread systemic disease prevails significant chance long-term cure systemic therapy data retrospective reviews preliminary data prospective trials recent well-conducted animal studies chemotherapy hormonal deprivation effective tumor volumes evidence removal cancer possible early institution systemic treatment Caution aforementioned evidence cases extensive prostate cancer patients bulky pelvic disease distant metastasis significant elevation serum markers doubtful removal prostate lymph nodes justifiable advantages patients Whether removal prostate affords local palliative benefit issue debate primary tumor untreated symptoms procedures patients incidence local recurrence adverse effects recurrences patients disease radical prostatectomy adjuvant therapy cent Surgical refinements low morbidity radical prostatectomy authors palliative benefits primary tumor patients purpose article aggressive treatment patients stage prostate cancer evidence long-term survival endpoint treatment groups date treatment option offers significant advantages contrary progression rates disease-free survival cytoreductive surgery early systemic adjuvant treatment testosterone deprivation chemotherapy significant advantages patients stage disease ploidy analysis receptor mapping oncogene assays today practical way patients multimodality treatment approaches ABSTRACT TRUNCATED AT WORDS